Search

Author/Creator Yoo, D. H.

2. FRI0164 Local tuberculosis incidence affects the rate of positive conversion in the quantiferon®-tb gold test among patients receiving infliximab or ct-p13 therapy. (23rd January 2014)

Authors:
Yoo, D. H.; Shevchuk, S.; Ramiterre, E.; Kovalenko, V.; Tee, M.; Tobias Arteaga, E.; Morales Olazabal, L.; Baranauskaite, A.; Bukauskiene, L.; Lim, M. J.; Lee, Y.-A.; Rednic, S.; Ahn, C.; Kim, H.; Park, W.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A426
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FRI0421 A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study. (23rd January 2014)

Authors:
Park, W.; Jaworski, J.; Brzezicki, J.; Gnylorybov, A.; Kadinov, V.; Goecke Sariego, I.; Abud-Mendoza, C.; Otero Escalante, W. J.; Kang, S. W.; Andersone, D.; Blanco, F.; Yoo, D. H.; Ahn, C.; Kim, H. U.; Braun, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A516
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. OP0068 A Phase 3 Randomised Controlled Trial to Compare CT-P13 with Infliximab in Patients with Active Rheumatoid Arthritis: 54 Week Results from the Planetra Study. (23rd January 2014)

Authors:
Yoo, D. H.; Racewicz, A.; Brzezicki, J.; Yatsyshyn, R.; Tobias Arteaga, E.; Baranauskaite, A.; Abud-Mendoza, C.; Navarra, S.; Eullaran, R.; Kadinov, V.; Goecke Sariego, I.; Byrne, P.; Park, W.; Lee, S. J.; Kim, H. U.; Müller-Ladner, U.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A73
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search